Mural Oncology plc (MURA)
USD 1.0
(-11.14%)
USD 1.0
(-11.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -255.84 Million USD | -759.87% |
| 2022 | 38.77 Million USD | -23.39% |
| 2021 | 50.61 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -93.77 Million USD | 63.35% |
| 2024 Q2 | -110.5 Million USD | -17.84% |
| 2023 Q4 | -255.84 Million USD | -876.22% |
| 2023 FY | -255.84 Million USD | -759.87% |
| 2023 Q3 | 32.96 Million USD | 112.83% |
| 2023 Q2 | -256.88 Million USD | 0.0% |
| 2022 FY | 38.77 Million USD | -23.39% |
| 2022 Q4 | 38.77 Million USD | 0.0% |
| 2021 FY | 50.61 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Keros Therapeutics, Inc. | -316.7 Million USD | 19.217% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 113.682% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1423.873% |
| AlloVir, Inc. | -62.69 Million USD | -308.095% |
| Precigen, Inc. | -481 Thousand USD | -53089.813% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -46.004% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -10941.865% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1281.452% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4265.922% |
| Acelyrin, Inc. | -216.9 Million USD | -17.953% |
| AbCellera Biologics Inc. | -55.94 Million USD | -357.353% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 330.759% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2032.495% |
| Agenus Inc. | 274.13 Million USD | 193.327% |
| Dyadic International, Inc. | -6.37 Million USD | -3911.274% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1505.743% |
| Lantern Pharma Inc. | -21.7 Million USD | -1078.822% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1361.143% |
| IO Biotech, Inc. | -140.69 Million USD | -81.837% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2203.407% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -230.329% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -98.153% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -357.975% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 517.655% |
| Alkermes plc | -166.73 Million USD | -53.439% |
| Aptorum Group Limited | 1.35 Million USD | 18952.935% |
| Ardelyx, Inc. | 34.51 Million USD | 841.316% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 6077.64% |
| Bicycle Therapeutics plc | -481.46 Million USD | 46.862% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 807.472% |
| Chimerix, Inc. | -25.51 Million USD | -902.637% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3771.645% |
| CRISPR Therapeutics AG | -150.84 Million USD | -69.607% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1238.231% |
| ESSA Pharma Inc. | -33.62 Million USD | -660.949% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3437.808% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3437.808% |
| NextCure, Inc. | -6.47 Million USD | -3850.023% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -406.61% |
| Onconetix, Inc. | 5.33 Million USD | 4898.763% |
| Opthea Limited | 28.15 Million USD | 1008.616% |
| PDS Biotechnology Corporation | -32.7 Million USD | -682.182% |
| GT Biopharma, Inc. | -1.02 Million USD | -24958.08% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -131.455% |
| ImmuCell Corporation | 10.99 Million USD | 2427.843% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -65.974% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2894.706% |
| Incyte Corporation | -3.17 Billion USD | 91.942% |
| Jaguar Health, Inc. | 29.39 Million USD | 970.481% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4893.761% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -5111.713% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1746.442% |
| ContextLogic Inc. | -232 Million USD | -10.277% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1580.744% |
| MiMedx Group, Inc. | -33.9 Million USD | -654.677% |
| MEI Pharma, Inc. | -3.7 Million USD | -6805.344% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2609.495% |
| Seer, Inc. | -4.24 Million USD | -5934.033% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4460.264% |
| Novavax, Inc. | -298.29 Million USD | 14.231% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1916.938% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3910.707% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -739.931% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -52.077% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 258.18% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3810.775% |
| Vaxcyte, Inc. | -368.22 Million USD | 30.52% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -360.033% |
| Pharming Group N.V. | 109.8 Million USD | 333.0% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -5.562% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1370.7% |
| PureTech Health plc | -167.19 Million USD | -53.019% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1020.53% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1281.452% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3503.423% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -14740.081% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3660.738% |
| Senti Biosciences, Inc. | 1.74 Million USD | 14803.621% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -38.588% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -4120.439% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 256535.366% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 40839.331% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -964.372% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -118.583% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2144.944% |
| ChromaDex Corporation | -24.04 Million USD | -963.885% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3268.128% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -980.555% |
| Precision BioSciences, Inc. | -85.41 Million USD | -199.547% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 514.885% |
| Innoviva, Inc. | 255.56 Million USD | 200.11% |
| Summit Therapeutics Inc. | 34.67 Million USD | 837.853% |
| GlycoMimetics, Inc. | -40.98 Million USD | -524.244% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -277.444% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -90.815% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -786.128% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -339511.596% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -728.99% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3021.995% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -8076.463% |
| Soligenix, Inc. | -4.95 Million USD | -5066.878% |
| Century Therapeutics, Inc. | 847 Thousand USD | 30305.785% |
| Kura Oncology, Inc. | -20.11 Million USD | -1171.712% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -525.136% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2946.475% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 14144.228% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -7902.596% |
| Autolus Therapeutics plc | -186.59 Million USD | -37.108% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -418.909% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 7.234% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 846.594% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 255.653% |
| GRI Bio, Inc. | -1.79 Million USD | -14161.037% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2748.065% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -669.291% |
| IGM Biosciences, Inc. | -72.6 Million USD | -252.372% |
| INmune Bio, Inc. | -25.41 Million USD | -906.82% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 269.487% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -405.03% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1474.479% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -8768.269% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 773.005% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -521.204% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 902.393% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 167.692% |
| Verastem, Inc. | -37.27 Million USD | -586.311% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2719.828% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -393.315% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1590.406% |
| Histogen Inc. | -7.48 Million USD | -3317.163% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1084.084% |
| Surrozen, Inc. | -32.66 Million USD | -683.257% |
| Organovo Holdings, Inc. | -1.5 Million USD | -16876.974% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5986.445% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1449.368% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 9879.931% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 6255.991% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2952.6% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -488.93% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1655.131% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 19.239% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -35332.374% |
| Apollomics, Inc. | -27.39 Million USD | -833.904% |
| Amarin Corporation plc | -191.04 Million USD | -33.921% |
| Mesoblast Limited | 55.96 Million USD | 557.165% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1654.272% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -911.557% |
| Synaptogenix, Inc. | -28.66 Million USD | -792.637% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -27233.654% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 625.0% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -29577.098% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3421.059% |
| Exelixis, Inc. | -73.05 Million USD | -250.23% |
| Better Therapeutics, Inc. | -860 Thousand USD | -29649.186% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -965.435% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -5.996% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 34858.16% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3339.612% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 20502.153% |
| Gritstone bio, Inc. | 39.49 Million USD | 747.868% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -204.209% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -9619.962% |
| Avid Bioservices, Inc. | 169.72 Million USD | 250.737% |
| Insmed Incorporated | 721.62 Million USD | 135.454% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2698.695% |
| MediWound Ltd. | -5.32 Million USD | -4707.272% |
| OmniAb, Inc. | 9.2 Million USD | 2879.996% |
| Alector, Inc. | -35.63 Million USD | -617.914% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 397.592% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -5091.619% |
| Zai Lab Limited | -775 Million USD | 66.988% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 175.125% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1088.585% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -210.188% |
| Immunic, Inc. | -45.34 Million USD | -464.277% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -32.414% |
| Veracyte, Inc. | -203.82 Million USD | -25.522% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 140.082% |
| FibroGen, Inc. | 56.76 Million USD | 550.69% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2973.026% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -8949.72% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -12257.488% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 105.574% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -7557.677% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -54.156% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1532.331% |
| Galecto, Inc. | -21.21 Million USD | -1105.896% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -975.649% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 116.302% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -945.452% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2123.368% |
| XBiotech Inc. | -200.02 Million USD | -27.907% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -204.209% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 5750.243% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -625.528% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -231.326% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4595.572% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -50.129% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -176.964% |
| Vaxxinity, Inc. | 10.13 Million USD | 2625.099% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 134.749% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2276.056% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -287.9% |
| NexImmune, Inc. | -3.13 Million USD | -8064.395% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -7309.998% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1593.041% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -844.07% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2750.284% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -205272.667% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -530.59% |
| Ainos, Inc. | 4.07 Million USD | 6373.848% |
| Pluri Inc. | 22.82 Million USD | 1220.693% |
| Prothena Corporation plc | -608.34 Million USD | 57.945% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -115.436% |
| Celularity Inc. | 65.19 Million USD | 492.457% |
| Rallybio Corporation | -24.1 Million USD | -961.501% |
| Cue Biopharma, Inc. | -33.81 Million USD | -656.507% |
| MeiraGTx Holdings plc | -40.3 Million USD | -534.815% |
| Omeros Corporation | 331.17 Million USD | 177.253% |
| Humacyte, Inc. | -22.48 Million USD | -1037.788% |
| Immunocore Holdings plc | -358.59 Million USD | 28.654% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -941.07% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -727.944% |
| Blueprint Medicines Corporation | 702.83 Million USD | 136.402% |
| CalciMedica, Inc. | -5.53 Million USD | -4526.456% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -35.928% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2404.827% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -539.016% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -669.383% |
| Pulmatrix, Inc. | -10.41 Million USD | -2356.014% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4180.458% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -570.765% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -129.657% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -326.803% |
| Cytokinetics, Incorporated | 642.37 Million USD | 139.828% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -4293.663% |
| Nutriband Inc. | -251.65 Thousand USD | -101563.375% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -649.855% |
| Vor Biopharma Inc. | 4.3 Million USD | 6049.837% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.761% |
| Evogene Ltd. | -19.63 Million USD | -1203.061% |
| ProKidney Corp. | -56.23 Million USD | -354.945% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -425.647% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2669.707% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 118.758% |
| CorMedix Inc. | -43.05 Million USD | -494.258% |
| BioLineRx Ltd. | 7.33 Million USD | 3587.5% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -831.524% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 654.409% |
| Atai Life Sciences N.V. | -28.55 Million USD | -795.872% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 11570.059% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1021.332% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1542.588% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -240.788% |
| MediciNova, Inc. | -50.78 Million USD | -403.791% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -224.653% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1137232.741% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3864.967% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -28.036% |
| Biomea Fusion, Inc. | -166.57 Million USD | -53.595% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -42.949% |
| Mereo BioPharma Group plc | -51.46 Million USD | -397.082% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -169.751% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 12.907% |
| Absci Corporation | -72.59 Million USD | -252.411% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5703.219% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -9.131% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -171.564% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -167.35% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -554.782% |
| Allakos Inc. | -24.97 Million USD | -924.396% |
| Imunon, Inc. | -4.21 Million USD | -5971.476% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1635.47% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -88.953% |
| BioAtla, Inc. | -109.01 Million USD | -134.695% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 34858.16% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -27146.326% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2238.083% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1106.636% |
| XOMA Corporation | -29 Million USD | -782.217% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1444.946% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2737.655% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3334.595% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -105.272% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -22.905% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -212.847% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -175.803% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -29677.44% |
| Akari Therapeutics, Plc | -3.84 Million USD | -6553.914% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 15864.654% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 118.528% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -21433.159% |
| UroGen Pharma Ltd. | 4.39 Million USD | 5926.532% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 325.45% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 355625.138% |
| Orgenesis Inc. | 21.78 Million USD | 1274.454% |
| Entera Bio Ltd. | -10.62 Million USD | -2307.028% |
| GH Research PLC | -78.07 Million USD | -227.68% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1047.896% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -859.687% |
| Xencor, Inc. | 29.64 Million USD | 963.052% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -12888.194% |
| Replimune Group, Inc. | 1.41 Million USD | 18219.193% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -104364.942% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -102.38% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -21433.159% |
| Portage Biotech Inc. | -4.98 Million USD | -5036.378% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1137232.741% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -286.926% |
| OncoCyte Corporation | -6.56 Million USD | -3798.263% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 28608.947% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -5515.958% |
| Purple Biotech Ltd. | -14.13 Million USD | -1709.612% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -976.962% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3808.984% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1432.713% |
| HilleVax, Inc. | -165.48 Million USD | -54.602% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -9980.496% |
| Tharimmune, Inc. | -10.93 Million USD | -2239.595% |
| Genprex, Inc. | -6.73 Million USD | -3697.226% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 30.63% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -189.219% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -18161.456% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -7613.21% |
| OKYO Pharma Limited | -826.84 Thousand USD | -30841.963% |
| Savara Inc. | 153 Thousand USD | 167317.647% |
| Curis, Inc. | -23.88 Million USD | -971.055% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4860.206% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -32868.949% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4021.182% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 21690.127% |
| BeiGene, Ltd. | -2.25 Billion USD | 88.645% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2173.534% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 57.935% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -37.857% |
| Erasca, Inc. | -37.21 Million USD | -587.454% |
| bluebird bio, Inc. | 108.57 Million USD | 335.646% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -19765.237% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 167.55% |
| DBV Technologies S.A. | -126.98 Million USD | -101.473% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -19765.237% |
| Moderna, Inc. | -2.9 Billion USD | 91.199% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2371.435% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2254.095% |
| Molecular Templates, Inc. | 707 Thousand USD | 36287.129% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -715.54% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 173.813% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -211.768% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -178.909% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -692.771% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -644.249% |
| MacroGenics, Inc. | -66.98 Million USD | -281.941% |
| RenovoRx, Inc. | -1.17 Million USD | -21710.997% |
| Adicet Bio, Inc. | -138.78 Million USD | -84.342% |
| Prime Medicine, Inc. | -27.94 Million USD | -815.654% |
| Aditxt, Inc. | 18.12 Million USD | 1511.868% |
| Adagene Inc. | -87.62 Million USD | -191.967% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6042.058% |
| Quantum-Si incorporated | -118.55 Million USD | -115.797% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 810.576% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3323.021% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -427.413% |
| SciSparc Ltd. | -2.06 Million USD | -12289.492% |
| Vericel Corporation | 1.27 Million USD | 20134.691% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2033.5% |
| Minerva Neurosciences, Inc. | 41 Million USD | 723.943% |
| Generation Bio Co. | 31.44 Million USD | 913.543% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -45.893% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -727.355% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 319.433% |
| Invivyd, Inc. | -198.47 Million USD | -28.904% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -183.42% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -10570.403% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -261.411% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3648.615% |
| 2seventy bio, Inc. | 181.71 Million USD | 240.794% |
| ADMA Biologics, Inc. | 90.06 Million USD | 384.062% |
| Clene Inc. | 3.34 Million USD | 7759.97% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2716.816% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1089.359% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3864.967% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 25.654% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -884.024% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 244.002% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -6152.934% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 5214.814% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4811.557% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -96.343% |
| Evaxion Biotech A/S | 5.28 Million USD | 4939.239% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -127.279% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -94.894% |
| Trevena, Inc. | 2.25 Million USD | 11430.514% |
| Surrozen, Inc. | -32.66 Million USD | -683.257% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -396.686% |
| Cingulate Inc. | 3.08 Million USD | 8399.361% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -8611.032% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3659.802% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2653.598% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -222.533% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -94.628% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -142.409% |
| Clearmind Medicine Inc. | -3.94 Million USD | -6389.134% |
| Kronos Bio, Inc. | -36.05 Million USD | -609.611% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2819.131% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 17646.003% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -371.548% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1874.666% |
| ImmunityBio, Inc. | 618.22 Million USD | 141.384% |
| Korro Bio, Inc. | -132.94 Million USD | -92.446% |
| Kineta, Inc. | -4.54 Million USD | -5534.067% |
| BioVie Inc. | -17.73 Million USD | -1342.804% |
| Codexis, Inc. | -43.27 Million USD | -491.257% |
| Celularity Inc. | 65.19 Million USD | 492.457% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -7973.304% |
| Celcuity Inc. | 6.78 Million USD | 3871.544% |
| Virax Biolabs Group Limited | -3.36 Million USD | -7503.187% |
| Cibus, Inc. | -8.07 Million USD | -3067.158% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -5949.728% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 5698.315% |
| IN8bio, Inc. | -16.38 Million USD | -1461.065% |
| Kodiak Sciences Inc. | -103.87 Million USD | -146.299% |
| Annexon, Inc. | -193.75 Million USD | -32.045% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 710775.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1362.044% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -7182.75% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 124.267% |
| Eyenovia, Inc. | 1.25 Million USD | 20425.939% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1050.912% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7789.084% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -669.522% |
| Arcellx, Inc. | -296.95 Million USD | 13.845% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1211.612% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -334.553% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1134.347% |
| Moolec Science SA | 117.61 Thousand USD | 217623.976% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -566.275% |
| Geron Corporation | 14.76 Million USD | 1833.236% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -574.727% |
| Royalty Pharma plc | 5.65 Billion USD | 104.522% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -80.909% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3560.43% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4670.646% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -81.796% |
| Humacyte, Inc. | -22.48 Million USD | -1037.788% |
| Structure Therapeutics Inc. | -124.33 Million USD | -105.762% |
| 89bio, Inc. | -289.05 Million USD | 11.489% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -913.561% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -14249.019% |
| Genelux Corporation | -6.89 Million USD | -3608.407% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -723.732% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 406.036% |
| Notable Labs, Ltd. | -9.77 Million USD | -2517.052% |
| Liquidia Corporation | -80.17 Million USD | -219.102% |
| Mustang Bio, Inc. | -3.73 Million USD | -6748.046% |
| Immunovant, Inc. | -635.22 Million USD | 59.724% |
| Quantum-Si incorporated | -118.55 Million USD | -115.797% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1356.633% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -6075.308% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3287.28% |
| Acasti Pharma Inc. | -23 Million USD | -1012.119% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -7498.028% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1474.479% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -85.743% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -8109.669% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1050.787% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1277.796% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -51.138% |
| PepGen Inc. | -60.67 Million USD | -321.696% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1013.523% |
| United Therapeutics Corporation | -507.7 Million USD | 49.607% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1237.671% |
| Solid Biosciences Inc. | -47.75 Million USD | -435.797% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -29577.098% |
| Immuneering Corporation | -54.94 Million USD | -365.653% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5986.445% |
| Silo Pharma, Inc. | -3.52 Million USD | -7159.383% |
| Belite Bio, Inc | -87.27 Million USD | -193.159% |
| XOMA Corporation | -29 Million USD | -782.217% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -261.887% |
| Bionomics Limited | 227 Million USD | 212.701% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -120.019% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -10000.395% |
| uniQure N.V. | -102.95 Million USD | -148.509% |
| Cassava Sciences, Inc. | -121.13 Million USD | -111.203% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6042.058% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 724.754% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2038.977% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -8168.47% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 241461.321% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7789.084% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2973.026% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3349.879% |
| Altimmune, Inc. | -134.48 Million USD | -90.236% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 229.171% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -10000.395% |
| Compugen Ltd. | -12.9 Million USD | -1882.664% |
| Peak Bio, Inc. | 10.34 Million USD | 2574.266% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -90303.887% |
| Benitec Biopharma Inc. | -50.58 Million USD | -405.799% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -145.206% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1402.331% |
| Zura Bio Limited | -99.8 Million USD | -156.34% |
| PolyPid Ltd. | 6.17 Million USD | 4246.564% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 445.174% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1402.331% |
| Instil Bio, Inc. | 75.35 Million USD | 439.503% |
| argenx SE | -2.02 Billion USD | 87.39% |
| Immunome, Inc. | -97.02 Million USD | -163.677% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1037.333% |
| Verona Pharma plc | -220.44 Million USD | -16.059% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -256.61% |
| Shattuck Labs, Inc. | -121.42 Million USD | -110.702% |
| CervoMed Inc. | -7.79 Million USD | -3183.05% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -37.921% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -5750.515% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -94.203% |
| Moolec Science SA | 117.61 Thousand USD | 217623.976% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -11082.062% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1709.239% |
| AnaptysBio, Inc. | -18.15 Million USD | -1309.526% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1309.603% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -263.511% |
| NeurAxis, Inc. | 145.7 Thousand USD | 175695.745% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2377.804% |
| Lumos Pharma, Inc. | -28.49 Million USD | -797.915% |
| Achilles Therapeutics plc | -126.92 Million USD | -101.572% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -256.61% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -38916.516% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1131.564% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 17646.003% |
| Nutriband Inc. | -251.65 Thousand USD | -101563.375% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1842.472% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3338.75% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 175.204% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1177.914% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 42.825% |
| Palisade Bio, Inc. | -12.06 Million USD | -2020.89% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -82.34% |
| Beam Therapeutics Inc. | -262.72 Million USD | 2.618% |
| Neurogene Inc. | -131.95 Million USD | -93.887% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1272.731% |
| AEON Biopharma, Inc. | -4.88 Million USD | -5142.684% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 32.171% |
| Sesen Bio, Inc. | -112.55 Million USD | -127.309% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -156.202% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -10797.17% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -555.571% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -207.201% |
| Athira Pharma, Inc. | -88.99 Million USD | -187.467% |
| Vaccinex, Inc. | -1.28 Million USD | -19763.587% |
| HCW Biologics Inc. | 2.85 Million USD | 9055.968% |
| XOMA Corporation | -29 Million USD | -782.217% |
| Nektar Therapeutics | 210.24 Million USD | 221.691% |
| Arvinas, Inc. | -313.8 Million USD | 18.469% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 15864.654% |
| Merus N.V. | -192.88 Million USD | -32.641% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 526.512% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3587.561% |
| Rezolute, Inc. | -68.16 Million USD | -275.312% |
| Clene Inc. | 3.34 Million USD | 7759.97% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1840.115% |
| BeyondSpring Inc. | -13.75 Million USD | -1760.0% |
| Synlogic, Inc. | -6.68 Million USD | -3727.12% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 22661.111% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2925.937% |
| Peak Bio, Inc. | 10.34 Million USD | 2574.266% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -210.414% |
| Krystal Biotech, Inc. | -350.23 Million USD | 26.951% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 306.117% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -51.39% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -8003.622% |
| MannKind Corporation | 143.89 Million USD | 277.793% |
| Ikena Oncology, Inc. | -109.15 Million USD | -134.383% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3279.25% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -672.94% |
| Gossamer Bio, Inc. | 180.35 Million USD | 241.855% |
| CohBar, Inc. | -5.93 Million USD | -4213.853% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -760.034% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5703.219% |
| Legend Biotech Corporation | -949.39 Million USD | 73.052% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 894.174% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -5331.171% |
| Disc Medicine, Inc. | -358.28 Million USD | 28.592% |
| Champions Oncology, Inc. | 4.81 Million USD | 5416.771% |
| REGENXBIO Inc. | 54.76 Million USD | 567.14% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -95041.815% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -69.406% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2738.913% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -217.097% |
| Vaxart, Inc. | -8.24 Million USD | -3004.514% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -409.851% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -101.189% |
| Cellectis S.A. | -43.85 Million USD | -483.384% |
| Longeveron Inc. | -2.9 Million USD | -8697.902% |
| Repare Therapeutics Inc. | -107.85 Million USD | -137.204% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 126.42% |
| Inozyme Pharma, Inc. | 12 Million USD | 2231.315% |
| Revolution Medicines, Inc. | -608.2 Million USD | 57.935% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -20700.244% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 3.498% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -70.48% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1535.093% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -34473.378% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.325% |
| Denali Therapeutics Inc. | -74.86 Million USD | -241.739% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2033.5% |
| Veru Inc. | 4.77 Million USD | 5452.399% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2174.969% |
| Cingulate Inc. | 3.08 Million USD | 8399.361% |
| Passage Bio, Inc. | 4.58 Million USD | 5680.0% |
| Context Therapeutics Inc. | -14.44 Million USD | -1670.561% |
| Exicure, Inc. | 5.84 Million USD | 4474.132% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -11.055% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -546.558% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1730.508% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -334.952% |
| Nuvalent, Inc. | -335.38 Million USD | 23.717% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 14851.597% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -243.496% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2777.874% |
| OmniAb, Inc. | 9.2 Million USD | 2879.996% |
| Anew Medical, Inc. | 1.43 Million USD | 17960.332% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1661.756% |
| Lipocine Inc. | -4.75 Million USD | -5280.966% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -132.949% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1779.752% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -405.03% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1127.812% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3706.621% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -288.66% |
| Ocugen, Inc. | -32.52 Million USD | -686.701% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -198.969% |
| Q32 Bio Inc. | -37.94 Million USD | -574.194% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -40639.331% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1791.071% |
| Equillium, Inc. | -22.39 Million USD | -1042.564% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -900.638% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -684.151% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -103097.87% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 290.868% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 8100.094% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 77996.182% |
| Dominari Holdings Inc. | 195 Thousand USD | 131301.538% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4757.554% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2769.16% |
| Bio-Techne Corporation | 267.74 Million USD | 195.554% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1478.401% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -116.644% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2944.663% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1922.314% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -4.375% |
| Nkarta, Inc. | 57.29 Million USD | 546.505% |
| BioCardia, Inc. | 212 Thousand USD | 120780.66% |
| Iterum Therapeutics plc | 13.43 Million USD | 2003.877% |